Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
He’s touched every ꓘ at The K for 25 years; meet the man who gives mud baths to 200+ balls before each game
Every baseball that crosses home plate at Kauffman Stadium likely received a mud bath from Tom Walsh, he shared. Before every home game — including opening day March 28 — the Kansas City Royals clubhouse and umpire services manager is in charge of preparing 204 balls in line with the strict regulations of Major League…
First look: Chef behind Strang Hall favorite Anousone brings his popular Laotian fare downtown
A new menu option at the Strang Chef Collective at lightwell hits familiar flavors for diners who already have fallen in love with renowned Chef Anourom Thomson’s Southeast Asian-inspired comfort food, said Shawn Craft. Anousone — a popular staple with the Strang Hall food hall concept in downtown Overland Park — has opened a new…
$30K grand prize: Sisters embrace vegan comfort eats potential with Mattie’s Food’s big win
Arvelisha Woods and India Monique plan to use their grand prize winnings from Friday’s We Are Black pitch competition to invest in the community’s health, they said. Mattie’s Foods won $30,000 in the second annual G.I.F.T. event, which saw 10 Black-owned businesses vying for funding to fuel their business dreams. The winning co-founders of the…
‘Punching above our weight’: KC requests $75M in federal funds as region’s Tech Hubs effort builds even more momentum
Leaders of Kansas City’s Tech Hubs initiative won’t find out until this summer if the regional effort will receive a new round of federal funding, but there’s already plenty to cheer, shared Dennis Ridenour. “We fully expect to be here — or someplace like this — four or five months from now celebrating our region’s…